Adaptimmune adaptimmune.com


Public list: Smart Money VCs (6327) Pharma Startups (4709)

Adaptimmune is focused on the use of T cell therapy with engineered T cell receptors to treat cancer and infectious disease. Established in July 2008 with a research base in Oxford, UK and a clinical base in Philadelphia, US, the company aims to utilise the body's own machinery – the T cell – to target and destroy cancerous or infected cells by using engineered, increased affinity T cell receptor (TCRs) as a means of strengthening natural patient T cell responses. Adaptimmune undertakes all ...Show all

Adaptimmune is focused on the use of T cell therapy with engineered T cell receptors to treat cancer and infectious disease. Established in July 2008 with a research base in Oxford, UK and a clinical base in Philadelphia, US, the company aims to util...Show all

Company (IPO / Went public)

Phone: +44 (0) 1235 430000

Fax:

91 Park Drive, Milton Park
Abingdon
Oxon, OX14 4RY
United Kingdom

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Adaptimmune $298.4M May 6, 2015

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Adaptimmune Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 13 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
High affinity ny-eso t cell receptors Dec 14, 2015 Dec 06, 2016 Patent
T cell receptor display Apr 10, 2014 Sep 20, 2016 Patent
T cell receptor display Apr 09, 2014 Mar 08, 2016 Patent
High affinity hiv t cell receptors Jan 03, 2013 Feb 09, 2016 Patent
High affinity ny-eso t cell receptors Mar 26, 2012 Oct 13, 2015 Patent
See all 15 patents